PTSD, Veterans, and Medical Cannabis Research

Understanding the Role of Cannabis in PTSD Research

For those navigating the complexities of post-traumatic stress disorder (PTSD), understanding what the current science says can be a vital starting point. The following overview is based exclusively on peer-reviewed studies indexed in PubMed (the U.S. National Library of Medicine’s database of reviewed research). As research into these topics continues to evolve, this summary is intended for general education and does not constitute medical advice.

The Endocannabinoid System and Psychiatric Health

Much of the interest in cannabis stems from the endocannabinoid system (ECS). Research in Neuroscience bulletin describes the ECS as a mediator for many bodily processes, including memory, pain perception, and behavior. When these systems become unbalanced, it can lead to the heightened arousal and intrusive memories seen in PTSD. While standard medications like SSRIs and antipsychotics help many patients, research in Pharmacopsychiatry notes that a wide range of people still experience lingering distress after trauma.

Current Evidence on Safety and Efficacy

When looking at how cannabis might fit into a treatment plan, the evidence today is mixed. A systematic review in The Lancet Psychiatry found that the safety and effectiveness of cannabis as a primary treatment for mental and substance use disorders have not been established. Similarly, a scoping review in the Journal of Cannabis Research highlights that while cannabis use is rising in clinical settings, the evidence regarding its efficacy and safety for PTSD remains fragmented.

Some research looks at how mental health impacts physical outcomes. A study in JSES reviews, reports, and techniques examined patients after shoulder surgery and found that PTSD — which is linked to altered pain perception — may influence how a person recovers from a procedure.

Many people with PTSD also manage substance use disorders. A national study in The American Journal of Psychiatry analyzed data from 2022 and found sex-based differences in the psychiatric conditions that often appear alongside opioid, alcohol, and cannabis dependence.

Because this field is still being studied, these findings should not be taken as a recommendation for any specific treatment. If you have questions about your care, please consult a licensed physician to discuss what options are appropriate for your situation.

Further Reading:

• Systematic review on cannabinoid efficacy and safety (The Lancet Psychiatry)
• Study on PTSD and post-operative recovery (JSES reviews)
• Scoping review on cannabis for PTSD (Journal of cannabis research)